This inventor holds 1 USPTO granted patent. Top assignee: Omron Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Tomoki Iitawaki - Innovator in Blood Sugar Measurement Technology
Introduction
Tomoki Iitawaki is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medical technology, particularly in the area of blood sugar measurement devices. His innovative approach aims to enhance the accuracy and convenience of monitoring blood sugar levels for patients.
Latest Patents
Iitawaki holds a patent for a blood sugar measuring device that offers both non-invasive and minimally invasive options for measuring blood sugar levels. This device is designed to improve measurement accuracy by taking into account various factors such as patient mealtime, food intake, and insulin injections. The device adjusts the measured blood sugar value based on this input data, ensuring more reliable results. Additionally, it features a retry indicator that prompts users to repeat the measurement if the results fall outside a predetermined range. Iitawaki's patent represents a significant advancement in diabetes management technology, with 1 patent to his name.
Career Highlights
Tomoki Iitawaki is currently employed at Omron Corporation, a leading company in the field of healthcare technology. His work at Omron has allowed him to focus on developing innovative solutions that improve patient care and health monitoring.
Collaborations
Iitawaki collaborates with talented colleagues such as Muneo Tokita and Yusaku Sakoda. Their combined expertise contributes to the development of cutting-edge medical devices that address critical health challenges.
Conclusion
Tomoki Iitawaki's contributions to blood sugar measurement technology exemplify the impact of innovation in healthcare. His work not only enhances the accuracy of blood sugar monitoring but also improves the overall quality of life for patients managing diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
